| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3405160 | International Journal of Mycobacteriology | 2013 | 4 Pages |
Abstract
The following is a case of multidrug-resistant pulmonary tuberculosis (MDR-TB) that was treated successfully with a linezolid-containing regimen. It was found that linezolid is an efficient medicine for MDR-TB treatment with an acceptable side effect profile. Treatment was maintained for 18 months, and closely monitoring toxicities did not reveal evidence of any neurologic adverse effects. However, despite our expectation, thrombocytopenia was seen after 2 years follow-up.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Maham Farshidpour, Golnaz Ebrahimi, Mehdi Mirsaeidi,